Author

David M. Hyams

Observed names: D Hyams, D M Hyams, D. Hyams, D. M. Hyams, D.M. Hyams, DAVID HYAMS, David Hyams, David M Hyams

Observed institutions: National Institutes of Health, City Of Hope National Medical Center, Eisenhower Medical Center, Allegheny General Hospital, Desert Regional Medical Center, National Cancer Institute, National Institutes of Health Clinical Center, NSABP Foundation, University of Cincinnati, University of Cincinnati Medical Center

ORCID: 0000-0002-5680-9488

Observed ORCID: 0000-0002-5680-9488

OpenAlex ID: A5069340173

erbB-2 and Response to Doxorubicin in Patients With Axillary Lymph Node-Positive, Hormone Receptor- Negative Breast Cancer

1998 · Soonmyung Paik, John Bryant, et al. · JNCI Journal of the National Cancer Institute · 645

A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma

2011 · Omid Hamid, Henrik Schmidt, et al. · Journal of Translational Medicine · 547

PDF

A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum: A progress report of National Surgical Adjuvant Breast and Bowel Project protocol R-03

1997 · David M. Hyams, Eleftherios P. Mamounas, et al. · Diseases of the Colon & Rectum · 360

Magnetic Resonance Imaging Versus Computed Tomography in the Evaluation of Soft Tissue Tumors of the Extremities

1987 · ALFRED E. CHANG, YVEDT L. MATORY, et al. · Annals of Surgery · 155

Comparison of postoperative wound complications and early cancer recurrence between patients undergoing mastectomy with or without immediate breast reconstruction

1993 · William O'Brien, Per-Olof Hasselgren, et al. · The American Journal of Surgery · 107

Adjuvant 5-Fluorouracil and Leucovorin With or Without Interferon Alfa-2a in Colon Carcinoma: National Surgical Adjuvant Breast and Bowel Project Protocol C-05

1998 · N. Wolmark, R. Smith, et al. · JNCI Journal of the National Cancer Institute · 103

Characterization of a laminin receptor from human breast carcinoma tissue

1984 · Sanford H. Barsky, C. N. Rao, et al. · Breast Cancer Research and Treatment · 67

Laparoscopic splenectomy by the lateral approach: A safe and effective alternative to open splenectomy for hematologic diseases

1996 · C. Daniel Smith, Tory A. Meyer, et al. · Surgery · 63

Integrating 31-Gene Expression Profiling With Clinicopathologic Features to Optimize Cutaneous Melanoma Sentinel Lymph Node Metastasis Prediction

2021 · Eric D. Whitman, Vadim P. Koshenkov, et al. · JCO Precision Oncology · 62

PDF

Breast Cancer Chemoprevention Phase I Evaluation of Biomarker Modulation by Arzoxifene, a Third Generation Selective Estrogen Receptor Modulator

2004 · Carol J. Fabian, Bruce F. Kimler, et al. · Clinical Cancer Research · 60

Response to preoperative multimodality therapy predicts survival in patients with carcinoma of the rectum

2004 · M. S. Roh, L. Colangelo, et al. · Journal of Clinical Oncology · 58

Correlations among p53, Her-2/neu, and ras overexpression and aneuploidy by multiparameter flow cytometry in human breast cancer: evidence for a common phenotypic evolutionary pattern in infiltrating ductal carcinomas.

2000 · C A Smith, A A Pollice, et al. · PubMed · 46

Identification of risk in cutaneous melanoma patients: Prognostic and predictive markers

2018 · David M. Hyams, Robert W. Cook, et al. · Journal of Surgical Oncology · 42

PDF

Cediranib in combination with fulvestrant in hormone-sensitive metastatic breast cancer: a randomized Phase II study

2013 · David M. Hyams, Arlene Chan, et al. · Investigational New Drugs · 42

PDF

Impact of radiolabeled antibody imaging on management of colon cancer

1989 · J.David Beatty, David M. Hyams, et al. · The American Journal of Surgery · 35

Multigene assays in early breast cancer: Insights from recent phase 3 studies

2019 · C. Markopoulos, D.M. Hyams, et al. · European Journal of Surgical Oncology · 33

PDF

Simultaneous immunohistochemical detection of IUdR and BrdU infused intravenously to cancer patients.

1991 · M A Miller, C M Mazewski, et al. · Journal of Histochemistry & Cytochemistry · 27

PDF

Radioimmunotherapy of human colon carcinomatosis xenograft with 90Y-ZCE025 monoclonal antibody: toxicity and tumor phenotype studies.

1990 · J M Esteban, D M Hyams, et al. · PubMed · 27

Computed Tomography in Malignant Fibrous Histiocytoma

1982 · Michael R. Paling, David M. Hyams · Journal of Computer Assisted Tomography · 27

Therapy of Peritoneal Carcinomatosis of Human Colon Cancer Xenografts With Yttrium 90—Labeled Anti—Carcinoembryonic Antigen Antibody ZCE025

1987 · David M. Hyams · Archives of Surgery · 21

Selecting postoperative adjuvant systemic therapy for early stage breast cancer: A critical assessment of commercially available gene expression assays

2017 · David M. Hyams, Eric Schuur, et al. · Journal of Surgical Oncology · 18

PDF

Esophageal heterotopic pancreas presenting as an inflammatory mass

1995 · Amy E. Noffsinger, David M. Hyams, et al. · Digestive Diseases and Sciences · 18

Effect of yttrium-90-labeled anti-carcinoembryonic antigen monoclonal antibody on the morphology and phenotype of human tumors grown as peritoneal carcinomatosis in athymic mice

1989 · Jose M. Esteban, David M. Hyams, et al. · Cancer · 16

PDF

Evaluation of a short‐stay program for patients undergoing mastectomy

1989 · Lawrence D. Wagman, Jose J. Terz, et al. · Journal of Surgical Oncology · 15

Prolongation of Survival of Nude Mice Bearing Human Colon Cancer: Treatment With Yttrium 90—Labeled Anti—Carcinoembryonic Antigen Antibody

1989 · David M. Hyams · Archives of Surgery · 14

Works count: 45

Citation count: 2,684

H-index: 20

I10-index: 27